HITLAB Expands Breakthrough Alliance Board with the addition of Dr. Glennis Mehra, Director Biolabs at NYU Langone
HITLAB TEAM • October 16, 2023
New York, NY – October 16, 2023 – HITLAB is excited to announce the expansion of its Breakthrough Alliance Board, with the addition of Dr. Glennis Mehra, Director Biolabs at NYU Langone.
Dr. Mehra is a serial entrepreneur, investor, advisor and scientists with proven success in a variety of geographies and industries. Her experience spans teaching, biotechnology (biotech), technology transfer, international business operations, research. “I am thrilled to be joining the HITLAB Breakthrough Alliance as a new Board member” said Dr. Glennis Mehra, Director Biolabs at NYU Langone. “My multifaceted academic, commercial and international experience enables me to offer a unique and holistic point of view.”
“We are so happy to have Dr. Mehra joining our Breakthrough Alliance Board,” said Bill Taranto, President Merck Global Health Information Fund and Chair of the HITLAB Breakthrough Alliance. “With her proven success and diverse background, Dr. Mehra brings a lot to the table. We look forward to working with her.”
The BTA is a digital health consortium of executive leaders from across life science, pharmaceutical, academic medical institutions, and healthcare providers, including New York City Economic Development Corporation, Merck Global Health Innovation, Johnson & Johnson, Medidata, Fund LLC, BDO, Atlas Venture, StartUp Health, CATALAIZE, Consummate Capital, EdgeOne Medical, Esplanade Ventures, FFF Solutions and Northwell Health, all committed to improving health outcomes and care delivery through verified emerging technologies. The board is chaired by Bill Taranto, the CEO of the Merck Global Innovation Fund.
The BTA board meets every quarter. All members have the benefits of:
- Setting priorities to guide the development of research studies for selected digital health technologies
- Receiving exclusive access to investment and partnership opportunities with the latest digital health tech under development
- Gaining insights into the future of digital health by seeing the results of the verified and risk-reduced studies.
Established in 1998, HITLAB is a leading evidence-based, healthcare innovation lab specializing in the delivery of world-class digital health research and education. We help leading organizations ideate, create, and evaluate technology-based solutions to pressing healthcare challenges across the globe. HITLAB works with a wide variety of stakeholders in both the public and private sectors to design and disseminate studies, programs, and products that improve healthcare access and delivery.
About HITLAB Breakthrough Alliance
HITLAB Breakthrough Alliance is an accelerator that helps early-stage startups conduct rapid pilot studies to test their products and move closer to market. Selected startups have their technologies tested in pilot studies with clinical partners and patients, gathering the data needed to accelerate their concepts. To source startups, Breakthrough holds open innovation competitions and networking events that bring together the digital health and investment ecosystem.
Learn more about the